Jay Swanson in New York, New York

Home New York New York

Jay Swanson has Nurse Practitioner as his primary medical specialty. Their primary office is: 111 Broadway in New York, New York. There is an additional office location, for a total of two, for Jay Swanson that can be viewed further down.

They're a part of the: New York University medical group which has around 4,291 members. You can call their office at 212-263-9700 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2012 (around 12 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Jay Swanson Office Phone and Directions

Jay Swanson
New York University
111 Broadway
New York, New York 10006
212-263-9700

Patient Ratings
Please rate your experience with Jay Swanson below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 212-263-9700

Enter a starting address:

Healthcare Info for Jay Swanson

Medical School: Sorry, his university is not listed
Graduation Year: 2012
The Primary Medical Specialty for Jay Swanson is listed as: Nurse Practitioner
Approximate Years of Experience: 12
PAC (PECOS ID)#: 0840440798
NPI #: 1750644191
NPI Created On: 06/20/2012
NPI Last Updated Listed as: 03/22/2017
Primary Taxonomy Code: 363LA2200X
License Number:
F307721
Listed Gender: Male

They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $23

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 833324721

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: CARDIOVASCULAR;METABOLIC DISEASE

Name of Drug #1: ELIQUIS

Open Associated Drug #1: 0003-0893-21